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Abstract 
 
Background: Omphalocele is a midline abdominal hernia that conditions important rates of 
mortality and morbidity. Infants born with omphalocele have an increased risk of having 
structural and chromosomal anomalies or syndromes. It is a defect that requires surgical 
treatment with multiple postoperative comorbidities.  
Purpose: To identify and characterize the cases of omphalocele of a Level III Neonatal 
Intensive Care Unit and analyse the impact of clinical and demographic characteristics of 
both infant and mother in patients’ outcome. 
Methods: This is a retrospective study based on the record analysis of infants that have been 
hospitalized in the Neonatal Intensive Care Unit of Centro Hospitalar de São João with the 
diagnosis of omphalocele between 2003 and 2012. Seventeen patients fulfilled these criteria. 
For each one, data about pregnancy, maternal history, prenatal diagnosis, delivery, newborn, 
treatment and follow-up was collected and analysed.  
Results: The mean birth weight was 2748.47 grams and the median gestation age was 37 
weeks. Prenatal diagnosis was performed in 75% of the cases; median week of diagnosis was 
lower in patients that died. Overall, 57.1% (80% of deceased patients) had large defects. 
Major malformations were seen in 23.5% of cases most often in deceased infants. Low first 
minute Apgar score, need of inotropic support, more days of parenteral nutrition and lower 
birth weight had statistically significant impact on mortality. After surgical correction 31.3% 
died, 25% had a residual hernia and 13.3% has gastroesophageal reflux. 
Conclusion: The mortality rates of patients with the diagnosis of omphalocele are not 
negligible because of associated anomalies or postoperative complications. We’ve been able 
to correlate some clinical features with mortality and found out that patients who survive can 
have other comorbidities mainly in the first years of life. However the majority of infants are 
expected to have a good long-term development and quality of life. 	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Introduction 
 
Omphalocele is a midline abdominal hernia with an estimated incidence that ranges 
between 1.5 and 3 in 10000 live births. 1 It is covered by a membrane consisting of 3 layers 
(peritoneum, amnion and Wharton’s jelly). 1,2 The contents of the sac can include either 
abdominal and/or pelvic viscera yet bowel and liver are the most frequent organs involved 
and usually remain morphologically and functionally normal. 3 The diagnosis can be 
performed by a routine prenatal ultrasound after the 10th postmenstrual week. 4 
This is a congenital malformation that can be associated with important rates of 
mortality as well as long and short-term morbidity. Infants born with omphalocele have an 
increased risk of having structural and chromosomal anomalies or syndromes as well as an 
increased incidence of intra-uterine growth restriction, fetal death and premature labour. 1,5 It 
is a defect that requires surgical treatment which leads to multiple postoperative 
complications. 6 The size of the hernia is important to predict prognosis. 7 Patients can have 
several long-term medical problems such as gastroesophageal reflux, pulmonary 
insufficiency, recurrent lung infections and feeding disorders with failure to thrive. 3 
 The purpose of this study is to identify and characterize the cases of omphalocele of a 
Level III Neonatal Intensive Care Unit during a 10-year period and to analyse the impact of 
clinical and demographic characteristics of both infant and mother in patients’ outcome. 
 
Material and methods 
  
We searched the databases of Neonatology Care Unit of Centro Hospitalar de São 
João to identify patients who were admitted with the diagnosis of omphalocele from 1 
January 2003 and 31 December 2012. There were 17 patients that fit these criteria.  
Data were collected retrospectively by reviewing maternal and neonatal records. 
Maternal information collected included age, weight, weight gained during pregnancy, height, 
parity and history of previous or familiar congenital diseases. Pregnancy and prenatal data 
included the occurrence of fever, gestational diabetes or IUGR, drugs used during pregnancy, 
amniotic fluid volume, week and method of diagnosis, karyotype, mode and week of delivery. 
Neonatal information included gender, birth weight, Apgar scores, birth temperature, cardiac 
and respiratory frequencies, glycemic levels, blood pressure, pre and postoperative pH, 
characteristics of the omphalocele, associated structural anomalies or genetic syndromes, 
treatment, feeding features, total length of hospital stay, postoperative ventilatory and 
inotropic support and neonatal outcomes of interest. Mothers of live infants were contacted to 
confirm some data about pregnancy and follow-up of patients. 
For the purpose of this study a major anomaly was defined as an anomaly or 
malformation that creates significant medical problems for the patient or require specific 
surgical or medical management. A large omphalocele was considered when the diameter was 
superior to 4.5 cm. 8  
The Ethics Committee of our institution approved the retrospective study. 
Data collection was performed using Microsoft Excel v.14.0.0® and the statistical 
analysis was performed using IBM SPSS statistics 22®. The categorical variables were 
characterized by absolute and relative frequencies and continuous variables by mean (+/- 
standard deviation) if they had symmetric distribution and by median (minimum – maximum) 
if they had asymmetric distribution. We used Fisher’s exact test to analyse the categorical 
variables and Independent t test and Mann-Whitney U test for continuous variables, 
symmetric and asymmetric respectively. A p value inferior to 0.05 was considered 
statistically significant.   
 
Results 
 
 Demographic characteristics of our patients are presented in table I; table II sums up 
maternal characteristics.  
	   The median number of previous gestations was two (min – max: 1 – 4) and deliveries 
were one (min – max: 0 – 3) with five (38.5%) mothers having former abortions and one 
(7.7%) having two former ectopic pregnancies. Three (17.6%) mothers had gestational 
diabetes, three (21.4%) needed antibiotics during pregnancy, five (35.7%) and ten (83.3%) 
undertook vitamins and folic acid, respectively.  
 Prenatal diagnosis was made in 12 (75%) cases (one was performed by magnetic 
resonance and the remanding by ultrasonography) with four (25%) infants being diagnosed 
only at delivery (one of them with prenatal diagnosis of gastroschisis). The median week of 
diagnosis was 19 (min – max: 12 – 37) being lower in deceased group (15 weeks vs 22 
weeks), p=0.141 (table II). The karyotype was normal in 15 (100%) cases. The amniotic fluid 
was abnormal in two (13.3%) pregnancies and intrauterine growth restriction (IUGR) was 
found in two (11.8%) pregnancies, both of them in patients who lived (18.2%, p=0.838) – 
table II. Multiple pregnancies (n=2; 11.8%) were only seen in patients who end up dying, 
p=0.083. 
 There were four pregnancy terminations due to omphalocele during the course of the 
study, two of them due to omphalocele size, one to fetal concomitant complex heart 
pathology and the other to fetal holoprosencephaly.  
 Cesarean delivery was the most frequent type of delivery (12 cases (70.6%), five of 
which needed resuscitation at birth). Five (29.4%) patients had vaginal delivery, two of which 
needed birth resuscitation. In the deceased group the cesarean section was performed in four 
(80%) patients versus the vaginal delivery, p=0.622 (table III). 
 The clinical characteristics of the infants are presented in table III.  
 Omphalocele was considered small in six (42.9%) cases and large in eight (57.1%) 
cases. In the neonatal death group the frequency of large omphaloceles was remarkably 
higher (80% vs 44.4%, p=0.301). The contents of the defect were mainly bowel in eleven 
(84.6%) patients and liver in five (38.5%). Only two (15.4%) patients had other structures 
present in the hernia such as spleen and stomach (in one case) and omentum in another. There 
were no statistically significant differences in sac contents between the two groups. However 
there was a propensity for the liver presence in the dead group (75% vs 22.2%, p=0.217) and 
the presence of other structures was only seen in patients who died (50%, n=2, p=0.077). 
Bowel was present in nine surviving infants (100%) and two patients (50%) who died, 
p=0.077.  In the deceased group nine (90%) infants presented an intact sac and one (10%) had 
ruptured sac (p=0.400). 
 Newborn Apgar score at first minute was ≤  7 in seven patients (41.2%) with 
significant impact in the outcome (p=0.036). The median umbilical cord pH was 7.23 (7.12 – 
7.39) and median arterial postoperative pH was 7.33 (6.98 – 7.41). When comparing the two 
groups the median umbilical cord pH was higher in survivors than in non- survivors (7.29 vs 
7.18) and the median postoperative arterial pH was 7.33 vs 7.12, however none of them had 
impact on outcome (p=0.343 and p=0.438, respectively). 
 Other major malformations were seen in four (23.5%) patients, two of them with 
cardiac anomalies, one with diaphragmatic eventration and one with neurologic 
malformation. Genetic syndromes were present in four (23.5%) patients, two with Beckwith-
Wiedemann Syndrome (BWS), one with Cantrell Penthalogy and one with Pierre-Robin 
Sequence. Major malformations were more frequent in patients who died (60%, n=3) than in 
those who lived (9.1%, n=1), but these differences were not statistically significant (p=0.063). 
 All patients were operated during the first 24 hours of life. One patient underwent 
surgery in another institution. Four patients (25%) needed a stent placement and the same 
number was submitted to other surgeries during hospitalization either because of the 
omphalocele or other associated pathologies (both variables were present in 60% of the dead 
group and 9.1% of alive group, p=0.063).   
 During the hospitalization time four infants (25%) had hemodynamic instability 
needing inotropic support. All these patients died, p=0.003 (table III). Metabolic and 
electrolytic disorders occurred in six (37.5%) and four (25%) patients, respectively. Ten 
(58.8%) patients needed mechanical ventilation (100% of the deceased group and 45.5% of 
	  surviving patients, p=0.093) during a median time of three days (min – max: 2 – 317) 
(slightly higher in non-survivors - 5 vs 3 days – without statistical significance) (table III).   
 The median day to start enteric feeding was day three of life (2 – 15). Two infants 
(11.8%) were never fed enterally. Total enteral feeding was achieved at day eight (median, 
min – max: 2 – 228). Eleven patients (64.7%) had total parenteral nutrition (TPN) for a 
median time of seven days (min – max: 3 – 119) and this had a significant impact on 
outcome, p=0.024 (table III). Two patients (12.5%) presented abdominal compartment 
syndrome. 
 The median hospitalization length of stay was eight days (2 – 317) (table III).   
 Five patients (31.3%) died, two of whom were submitted to necropsy examination. 
Infants who were autopsied died from multiple organ dysfunction syndromes, one of them 
because of abdominal compartment syndrome and the other because of functional and 
metabolic immaturity.  
 On long-term follow-up three patients (25%) had a residual hernia (umbilical hernia 
was present in two and supraumbilical hernia in one) and two (13.3%) had gastroesophageal 
reflux. All this patients had their conditions treated within the first three years of live. Ten 
patients had follow-up consultations in our hospital. The two patients with BWS had several 
comorbidities that justified their medical needs.  
One patient was transferred to another hospital, being a missing case in the follow-up.  
 
Discussion 
 
Omphalocele is a congenital anomaly associated with several risk factors such as 
advanced and very young maternal age, African American race, maternal obesity, no use of 
multivitamins during pregnancy, disturbed glycemic control, maternal history of febrile 
illness, in vitro fertilization, mutations in several genes and abnormal mothers’ karyotype. 9 
We weren’t able to study all these factors but we could notice that 50% of mothers were 
obese which impacted on outcome.  
Unlike previous studies where a male predominance of this pathology was noted 9, in 
our series there was a slight predominance of female patients.  
In our study a low birth weight was significantly correlated to prognosis. Infants who 
died were clearly underweighted. Our data is in accordance to other authors that reported 
similar results. 6 
 Although omphalocele diagnosis is usually made by a routine ultrasonography after 
the 10th postmenstrual week 4, we had some patients who were only diagnosed at birth. 
Overall the infants who died were diagnosed earlier, which is also reported by Nicholas et al. 
10 We hypothesised that this may be explained by the fact that larger defects may have a worst 
outcome 7 and are more likely to be detected earlier in the ultrasonography. On the other 
hand, we also know that alpha-fetoprotein maternal levels are elevated in 90% of cases. 11,12 
We couldn’t get enough data to conclude whether the levels of alpha-fetoprotein correlate to 
outcome because only two mothers were referred as having elevated levels.  
According to Ledbetter 1 up to one third of patients have associated chromosomal 
anomalies. However, in more recent studies these have been found in 54-57% of patients. 2 
Unlike these literature data, in our study all patients from whom we could access karyotype 
information presented a normal one. 
This congenital anomaly is also associated with an increased incidence of IUGR in 5 
to 35% of cases. 1 Our results are in accordance with this data since we found that 13.3% had 
IUGR and both of them survived.  
It is important to consider the impact of prenatal diagnosis in the decision of 
interrupting pregnancy. In one study 13 it was noticed that more than 50% of pregnancies were 
interrupted and in another one they found that 37% of omphaloceles were interrupted, even 
when isolated. 14 In our study four pregnancies were interrupted, two because of associated 
anomalies and the other two because of omphalocele size. 
The optimal time of delivery is at term. However this pathology is usually associated 
with preterm labour in 5 to 60% of cases. 1 We found out that 29.4% of patients were preterm 
	  and there were more preterm patients in the deceased group although without statistical 
significance.  
It is known that there is no improvement in neonatal outcomes for infants with 
abdominal wall defects who had cesarean delivery. 15 However, in accordance to other studies 
7 cesarean delivery was the most frequent type of delivery in both groups.  
There was a significant correlation between Apgar score at the first minute and 
outcome, since infants who had a score under or equal to 7 were mostly the ones who died. 
We also found the same tendency in the fifth minute score (without statistical significance).  
The risk of an associated structural or chromosomal abnormality in an infant with 
omphalocele ranges from 27% to 63%. 5 In our sample the frequency was lower with 
associated major malformations or genetic syndromes found in 23.5%. The frequency of 
major anomalies was much higher in the deceased group and even though, as others 16, we 
found no statistically significant results, it has been described that this is one of the most 
important risk factor for both mortality and morbidity. 2 The most frequently associated 
structural anomalies are cardiac (30% to 50% of cases) and gastrointestinal malformations 1, 
which is actually what happened in our study. Genetic syndromes usually associated with 
omphalocele are BWS, pentalogy of Cantrell and OEIS (omphalocele, bladder or cloacal 
exstrophy, imperforate anus and spinal anomalies). 1 There were two neonates with BWS in 
our series of cases; this has a reported prevalence of 13 to 33% in infants with omphalocele 
and normal karyotypes and since the diagnosis can be made prenatally it is of extreme 
importance to take this syndrome into account when counselling. 16  
Past reports showed that the size of the defect has an important impact in the 
prognosis mainly if there are no associated anomalies and karyotype alterations. 7 Since our 
patients had normal karyotypes this is an essential aspect to take into consideration. Despite 
the fact that 57.1% of our cases had a small omphalocele, in the non-survivors group 80% of 
patients had an omphalocele considered large (44.4% in the survivors group). So, we can 
hypothesise that there is an important role of the size of hernia in the prognosis. It is still in 
discussion the exact cut-off that should be used in omphaloceles and it is very important to 
proceed to studies that help to understand what should be considered big enough to actually 
have a significant impact on outcome. Another subject of discussion is whether the 
extracorporeal liver can be sufficient to define an omphalocele as giant. According to some 
authors the presence of the liver in the sac is a predictor of reserved prognosis, however there 
are others that believe in the exact opposite theory. 17 In our sample we verified that in fact 
the majority of patients who had liver in the sac died and 75% of patients who died had it. 
Besides, all the patients who lived and only 50% of patients who died had only bowel in the 
sac and only patients who had other structures involved in the hernia (such as omentum, bass 
and stomach) died. This gives us the idea that there are important differences and impacts in 
the outcome according to organs present in the sac. Islam 7 believes that the outcomes of 
ruptured omphalocele are substantially poorer than non-ruptured ones. We cannot support 
these results with our data since we only had one infant with ruptured sac who died. 
The time and type of surgery vary according to the gestational age, size, 
characteristics of the defect, clinical status of the patient and the associated problems. For 
small omphaloceles the primary closure of the hernia should be done, however in larger 
defects this might be difficult due to the small abdominal cavity and the increased risk of 
intra-abdominal pressure. In this case a staged closure can be performed. 3,6 What we actually 
verified in our study is that only one patient had two surgeries to repair the defect (all others 
had a primary closure and 93.8% had it in the first day of life). Sometimes it is necessary to 
place a prosthetic patch, preferably using the bio absorbable material to prevent infection. 3,6 
In our sample 25% of patients needed a prosthetic path and a correlation, although not 
significant, between its use and outcome was noted. Because there were no differences 
between the two groups concerning the type and time of surgery we can’t conclude about the 
impact of it in the outcome.  
Previous studies reported surgical morbidities in up to 27% of patients. 16 There are 
remarkable differences in the prognosis of patients with comorbidities when compared with 
the ones without them. Mechanical ventilation was seen in all patients who died and only in 
	  half the patients who lived who were ventilated for fewer days. Some authors reported that 
early respiratory distress or insufficiency were a strong predictor of poor outcome in large 
omphaloceles. Pulmonary complications are a significant survival limiting factor, namely 
pulmonary hypoplasia that is more associated with large defects. 7 In our sample 25% of 
patients had pulmonary disorders. We also realized that the need of inotropic support because 
of hemodynamic instability is correlated with bad outcome, since all our patients that needed 
it ended up dying.   
Because of the nature of the disease most patients needed TPN. This is confirmed by 
our data that show TPN need in 64.7% of newborns. Even though it was more prevalent in 
survivors, actually the days of TPN were statistically correlated with the bad outcome. 
Past reports have shown a perinatal mortality rate of approximately 30% 17 which was 
confirmed by our data, with isolated omphaloceles presenting survival rates between 75 to 
95%. 16 Yet, as stated above, not only mortality but also morbidity are important. Besides the 
hospitalization and postoperative morbidity already discussed, when it comes to early life 
follow-up these patients usually undergo several surgeries both related to omphalocele and 
other pathologies. In our sample 25% of patients needed other surgeries during the first two 
years of life. Some of them were because of residual hernias (35% of cases). According to 
Floortje et al 18 gastrointestinal disorders are common in patients with omphalocele; our data 
support these findings since we have 13.3% of patients with gastroesophageal reflux, one 
infant with gallbladder stones and several cases of feeding problems and intolerance both 
during hospitalization and after discharge. However all the patients, from whom we have 
access to information, were discharged from the consultation within the first three years of 
life except the two diagnosed with BWS that still need medical support with several 
comorbidities not related directly with omphalocele. This makes us believe that if there are no 
associated anomalies the long-term quality of life is overall good, as stated by Floortje et al 18 
despite the several early life comorbidities and procedures these patients need.   
 
 Conclusion 
 
Our data supports that the mortality rates of patients with the diagnosis of 
omphalocele are not negligible mainly because there are important comorbidities either 
related to the associated anomalies or to the postoperative complications. We’ve been able to 
correlate some clinical features such as the low Apgar score and the need of inotropic support 
as well as the time of TPN with mortality and found out that even patients who survive can 
have other comorbidities mainly in the first years of life. This should be considered when 
managing patients in early life, promoting predicting and preventing actions in order to 
increase the survival rates and the patients’ quality of life. Even patients who have normal 
karyotypes and without associated anomalies can have poor outcomes but most frequently 
they are expected to have a good long-term development and quality of life. 
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  Table I: Demographic characteristics. 
 
 Total 
(n=17) 
Deceased 
(n=5) 
Alive 
(n=11) p value 
Gender, n (%) 
     Male 
     Female 
 
8 (47.1) 
9 (52.9) 
 
2 (40) 
3 (60) 
 
5 (45.5) 
6 (54.5) 
 
0.838* 
Gestational Age, weeks, median  
(min – max) 37 (30 – 39) 36 (30 – 38) 38 (36 – 39) 0.069
¥ 
Birth Weight, grams, mean (± SD) 2748.47 (± 809.697) 1998 (± 579.068) 3108,18 (± 697.661) 0.008§ 
* Fisher’s exact test, § Independent t test, ¥Mann-Whitney U test 
 
 
 
Table II: Maternal characteristics.  
 
 Total (n=17) 
Deceased 
(n=5) 
Alive 
(n=11) p value 
Age, mean (± SD) 29.29 (±  5.324) 30.80 (± 3.114) 28.18 (± 6.063) 0.383§ 
Body Mass Index, median (min – 
max) 29.950 (23.7 – 39.2) 31 (29.7 – 39.2) 28.200 (23.7 – 35.3) 0.315
¥ 
Obesity, n (%) 6 (50) 3 (75) 3 (42.9) 0.545* 
Multiple pregnancy, n (%) 2 (11.8) 2 (40) 0 (0) 0.083* 
Prenatal diagnosis, weeks, median 
(min – max) 19 (12 – 37) 15 (12 – 18) 22 (12 – 37) 0.141
¥ 
Complications during pregnancy, n 
(%) 
Gestational diabetes 
IUGR 
Antibiotics therapy 
 
 
3 (17.6) 
2 (11.8) 
3 (21.4) 
 
 
1 (20) 
0 (0) 
2 (66.7) 
 
 
2 (18.2) 
2 (18.2) 
1 (10) 
 
 
0.931* 
0.838* 
0.108* 
IUGR – Intrauterine growth restriction 
* Fisher’s exact test, § Independent t test, ¥Mann-Whitney U test 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  Table III: Clinical characteristics. 
 
 Total 
(n=17) 
Deceased 
(n=5) 
Alive 
(n=11) p value 
Type of delivery, n (%) 
     Vaginal 
     Cesarean  
 
5 (29.4) 
12 (70.6) 
 
1 (20) 
4 (80) 
 
4 (36.4) 
7 (63.6) 
 
0.622* 
Apgar Score, n (%) 
1st minute ≤ 7 
> 7 
5th minute ≤ 7               
> 7   
 
 
7 (41.2) 
10 (58.8) 
 
3 (17.6) 
14 (82.4) 
 
 
4 (80) 
1 (20) 
 
2 (40) 
3 (60) 
 
 
2 (18.2) 
9 (81.8) 
 
1 (9.1) 
10 (90.9) 
 
 
0.036* 
 
 
0.214* 
Resuscitation at birth, n (%) 8 (47.1) 4 (80) 3 (27.3) 0.106* 
Umbilical cord pH, median  
(min – max) 
7.23  
(7.12 – 7.39) 
7.18 
(7.12 – 7.27) 
7.29 
(7.12 – 7.39) 0.343
¥ 
Arterial post operative pH, median 
(min - max) 
7.33  
(6.98 – 7.41) 
7.12  
(6.98 – 7.41) 
7.33  
(7.28 – 7.41) 0.438
¥ 
Omphalocele volume, n (%) 
     Small  
     Large 
 
6 (42.9) 
8 (57.1) 
 
1 (20) 
4 (80) 
 
5 (55.6) 
4 (44.4) 
 
0.301* 
Omphalocele contents, n (%) 
     Bowel 
     Liver 
     Other organs 
 
11 (84.6) 
5 (38.5) 
2 (15.4) 
 
2 (50) 
3 (75) 
2 (50) 
 
9 (100) 
2 (22.2) 
0 (0) 
 
0.077* 
0.217* 
0.077* 
Omphalocele type, n (%) 
With sac 
Without sac 
 
9 (90) 
1 (10) 
 
3 (75) 
1 (25) 
 
6 (100) 
0 (0) 
 
0.400* 
Major malformations, n (%) 4 (23.5) 3 (60) 1 (9.1) 0.063* 
Gastroesophageal reflux, n (%) 2 (13.3) 1 (20) 1 (10) 0.591* 
Residual hernia, n (%) 3 (25) 0 (0) 3 (30) 0.371* 
Stent placement, n (%) 4 (25) 3 (60) 1 (9.1) 0.063* 
Other surgeries during 
hospitalization, n (%) 4 (25) 3 (60) 1 (9.1) 0.063
* 
Mechanical ventilation, n (%) 10 (58.8) 5 (100) 5 (45.5) 0.093* 
Total parenteral nutrition, n (%) 11 (64.7) 3 (60) 8 (72.7) 0.611* 
Inotropic support, n (%) 4 (25) 4 (80) 0 (0) 0.003* 
Days of mechanical ventilation, 
median (min – max) 3 (2 – 317) 5 (2 – 317) 3 (2 – 3) 0.095
¥ 
Days of total parenteral nutrition, 
median (min – max) 7 (3 – 119) 56 (8 – 119) 6 (3 – 9) 0.024
¥ 
Days of hospitalization,  
median (min – max) 8 (2 – 317) 8 (2 – 317) 8 (2 – 14) 0.913
¥ 
* Fisher’s exact test, § Independent t test, ¥Mann-Whitney U test 
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